InsidersTradesSigma
Track the CLARITY PHARMACEUTICALS LTD share price and the full insider trade history of the company, a listed equity based in Australia. Shares are listed on AU AU, under the oversight of ASX. Market capitalisation: €891.7m. The latest transaction was reported on 7 July 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. The full history is free.
Analysts rate CLARITY PHARMACEUTICALS LTD Strong Buy (bullish), based on 4 analysts. Average price target: A$7.13.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
CLARITY PHARMACEUTICALS LTD is a company focused on developing innovative treatments for serious diseases. It is listed on the Australian Securities Exchange (XASX).